Polycystin-1 promotes PKCα-mediated NF-κB activation in kidney cells
Polycystin-1 promotes PKCα-mediated NF-κB activation in kidney cells
复制标题
DOI：
10.1016/j.bbrc.2006.09.042
复制
发表时间：
2006-11-17
影响因子：
3.1
通讯作者：
del Senno, Laura
中科院分区：
文献类型：
--
作者：
Banzi, Manuela;Aguiari, Gianluca;del Senno, Laura
Polycystin-1 (PC1), the PKD1 gene product, is a membrane receptor which regulates many cell functions, including cell proliferation and apoptosis, both typically increased in cyst lining cells in autosomal dominant polycystic kidney disease. Here we show that PC] upregulates the NF-kappa B signalling pathway in kidney cells to prevent cell death. Human embryonic kidney cell lines (HEK293(CTT)), stably expressing a PC1 cytoplasmic terminal tail (CTT), presented increased NF-kappa B nuclear levels and NF-kappa B-mediated luciferase promoter activity. This, consistently, was reduced in HEK293 cells in which the endogenous PC1 was depleted by RNA interference. CTT-dependent NF-kappa B promoter activation was mediated by PKC alpha because it was blocked by its specific inhibitor Ro-320432. Furthermore, it was observed that apoptosis, which was increased in PC1-depleted cells, was reduced in HEK293CTT cells and in porcine kidney LtTA cells expressing a doxycycline-regulated CTT. Staurosporine, a PKC inhibitor, and parthenolide, a NF-kappa B inhibitor, significantly reduced the CTT-dependent antiapoptotic effect. These data reveal, therefore, a novel pathway by which polycystin-1 activates a PKC alpha-mediated NF-kappa B signalling and cell survival. (c) 2006 Elsevier Inc. All rights reserved.
